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Within the two Nurses’ Health Study cohorts of US women, we examined whether higher intakes of vitamin C, vitamin E, retinol, or
individual tocopherols or carotenoids are associated with a lower risk of melanoma. We confirmed 414 cases of invasive melanoma
among over 162000 Caucasian women aged 25–77 years during more than 1.6 million person-years of follow-up. Diet was
measured every 4 years with a food frequency questionnaire and supplement use was reported every 2 years. Several measures of
sun sensitivity were assessed and included in proportional hazards models. We found that vitamins A, C, E and their individual
components were not associated with a lower risk of melanoma. Only retinol intake from foods plus supplements appeared
protective within a subgroup of women who were otherwise at low risk based on nondietary factors (relative risk (RR)¼0.39, 95%
confidence interval (CI) 0.22–0.71 for X1800 vs o400mgday
 1, P for linear trend¼0.01). Contrary to expectation, we observed
higher risks of melanoma with greater intakes of vitamin C from food only (RR¼1.43, 95% CI 1.01–2.00 for X175 vs
o90mgday
 1, P for linear trend¼0.05) and a significant positive dose–response with frequency of orange juice consumption
(P¼0.008). Further research is needed to determine whether another component in foods such as orange juice may contribute to
an increase in risk.
British Journal of Cancer (2003) 88, 1381–1387. doi:10.1038/sj.bjc.6600882 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: melanoma; retinol; tocopherol; carotenoid; antioxidant; diet; women
                                               
The incidence of melanoma in the US is increasing at a greater rate
than that of any other cancer site (Rigel, 1997), and this is
considered real and not because of earlier detection or changes in
diagnostic criteria (Dennis, 1999). Excessive exposure to sunlight
is the primary environmental risk factor for melanoma (Elwood
and Jopson, 1997; Osterlind et al, 1988). Ultraviolet (UV) radiation
from the sun produces free radicals that may initiate carcinogen-
esis through oxidative damage to DNA, and antioxidant nutrients,
such as carotenoids and vitamins E and C, can neutralize the free
radicals or even suppress their creation (Di Mascio et al, 1991; Frei,
1994). In animals, b-carotene and a-tocopherol can inhibit skin
tumours induced by UV light (Black and Chan, 1975). Preformed
vitamin A (i.e., retinol) is necessary for the regulation of cell
differentiation and can also reduce the incidence of skin tumours
in animals exposed to UV light (Levine and Meyskens, 1980;
Oikarinen et al, 1991). Certain carotenoids (e.g., a-carotene, b-
carotene, b-cryptoxanthin) are metabolised to retinol. These
retinol precursors along with antioxidant nutrients are prominent
components of fruits and vegetables and may account for the
observed anticancer effects of these foods (Ziegler, 1991).
Although antioxidants and retinol appear to be beneficial for
some cancers, little is known about their effect on the development
of melanoma. In case–control studies, lower risks of melanoma
have been associated with higher blood levels of a-tocopherol
(Knekt et al, 1991), b-carotene (Knekt et al, 1991), and retinol
(Breslow et al, 1995), and with greater dietary intakes of vitamin E
(Stryker et al, 1990; Bain et al, 1993; Kirkpatrick et al, 1994) and b-
carotene (Bain et al, 1993). Only one prospective study of diet and
melanoma has been reported and no associations were found for
carotenoids, retinoids, or vitamins C and E (Veierod et al, 1997),
although the questionnaire was inadequate for accurate assessment
of these nutrients.
In this prospective study within two cohorts of women, we
examined the risk of melanoma by intakes of vitamin C, vitamin E
and specific tocopherols, retinol, and b-carotene and other
carotenoids.
METHODS
Study populations
The Nurses’ Health Study (NHS) cohort consists of 121700 female
registered nurses living within 11 US states who were 30–55 years
of age when they responded to the initial questionnaire in 1976. A
second cohort of younger women, NHS II, was begun in 1989 with
116671 nurses 25–42 years of age across 14 US states. Both studies
were designed to examine prospectively the effects of lifestyle on
risk of chronic disease. Information on individual characteristics,
behaviours, and diagnosed diseases is collected with mailed
questionnaires every 2 years and a response rate of at least 90%
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through the National Death Index (Stampfer et al, 1984).
A baseline food frequency questionnaire (FFQ) was included in
the NHS and NHS II mailings in 1980 and 1991, respectively, and
diet has been reassessed at least every 4 years. In this analysis, we
used the 1984 FFQ as the baseline measure for the NHS cohort
since it contained 38 fruits and vegetables, significantly more than
the initial 1980 questionnaire (Feskanich et al, 2000).
The NHS and NHS II populations for this analysis consisted of
those participants who completed an FFQ at baseline and who had
no previous report of cancer (except nonmelanoma skin cancer).
Owing to small numbers and low risk, non-Caucasian women were
also excluded. After exclusions, 73525 women remained in the
NHS study population and 88553 women remained in the NHS II
study population.
Melanoma case confirmation
Within the study populations over the periods of follow-up for
these analyses, 571 NHS women and 378 NHS II women reported a
diagnosis of melanoma. Medical records were obtained for 486
(85%) of the NHS reports and for 289 (76%) of the NHS II reports;
254 (52%) and 160 (55%), respectively, were confirmed cases of
invasive melanoma. These included superficial spreading and
nodular types.
Diet and supplement use
For each food on the FFQ, women reported their frequency of
intake during the past year in terms of a specified serving size.
Daily dietary intakes of nutrients were calculated based on the
nutrient content of foods derived primarily from US Department
of Agriculture sources and supplemented with data from food
manufacturers and published research. Total daily nutrient intakes
were calculated by adding the amounts from multivitamins and
specific supplements to the intakes from food. Use of nutrient
supplements was assessed on each biennial questionnaire. For
multivitamins, participants provided the name brand and the
number of tablets taken per week. For vitamins C, E, and A
(retinol) supplements, participants specified their daily dosage.
For b-carotene supplements, reported use was assumed to be
6000mgday
 1.
Nutrient intakes were adjusted for total energy consumption
(Willett and Stampfer, 1986) and these values were cumulatively
updated in analyses to create the best estimates of long-term
intake. That is, at the beginning of every 2-year follow-up cycle,
each nutrient intake was calculated as the mean of all reported
intakes up to that time.
Results from several validation studies in the NHS cohort
indicate that nutrient intakes from the FFQ are valid for ranking
subjects in diet analyses. In a comparison of the 1986 FFQ with two
1-week diet records, correlations were 0.79 for vitamin A from
foods and 0.76 for vitamin C from foods (Willett, 1998). In other
studies, vitamin E and b-carotene intakes from the FFQ predicted
plasma levels of a-tocopherol (r¼0.55) (Stryker et al, 1988) and
b-carotene (r¼0.31) (Michaud et al, 1998), respectively.
In the NHS cohort, a brief FFQ was included in the 1986
questionnaire for reporting food consumption during high school.
These data were used to determine intakes earlier in life and to
identify women with consistent intakes in high school and adult
years.
Covariate information
In both cohorts, age, body weight, menopausal status, parity, and
use of oral contraceptives or postmenopausal hormones were
assessed in each 2-year follow-up cycle. Height was reported only
on the initial questionnaire and was used to calculate body mass
index (BMI, kgm
 2) in each cycle. Statistical analyses were also
controlled for the following factors: skin reaction after two or more
hours in the sun during childhood; number of sunburns over the
lifetime (NHS) or between ages 15 and 20 (NHS II); number of
moles on the left arm (NHS) or lower legs (NHS II); natural hair
colour at age 21; family history (parent or sibling) of melanoma;
and state of residence at cohort initiation. Information on
frequency of sunscreen use was also collected, but was not used
in analyses because it was unrelated to dietary intakes and was not
independently associated with a decreased risk of melanoma.
Statistical analyses
The NHS and NHS II cohorts were analysed separately. Person-
time was accrued for each participant from the return date of the
baseline questionnaire (mailed June 1984 for NHS; June 1991 for
NHS II) until a confirmed diagnosis of melanoma, a report of
another cancer, death, or end of follow-up (1 June 1998 for NHS; 1
June 1999 for NHS II). Total person-years in analysis included
956356 from NHS and 691784 from NHS II.
Current diet and covariate data were used to allocate person-
time to the appropriate category for each variable at the beginning
of each 2-year follow-up cycle. Age-adjusted incidence rates were
calculated within categories of diet and supplement use, and
relative risks (RRs) were then calculated as the ratio of risk in each
upper category compared to the risk in the lowest, or referent,
category. We used proportional hazards models to adjust the RRs
for all covariate information. To examine linear trend, dietary
intakes were entered into models as continuous values.
To increase precision and to obtain a single summary of the
results from NHS and NHS II, a random effects model
(DerSimmonian and Laird, 1986) was used to combine the RRs
and to test for heterogeneity of results (Po0.05).
RESULTS
Age-specific incidences of melanoma in the study populations
were similar to national rates. For example, for white women
50–54 years of age, rates were 25 out of 100000year
 1 in NHS and
27 out of 100000year
 1 in recent US data (Ries et al, 2002).
Table 1 shows the characteristics of the study populations within
low and high categories of vitamin C, vitamin E, retinol, and b-
carotene intakes from foods plus supplements. For all nutrients,
NHS women with higher intakes were older, and if postmenopau-
sal, were more likely to use postmenopausal hormones. NHS II
women with higher intakes were more likely to be nulliparous. In
both cohorts, the nondietary risk factors for melanoma were not
associated with nutrient intakes. Use of multivitamins and vitamin
C and E supplements were high in both cohorts (53, 35, 36%,
respectively, for NHS in 1998; 51, 27, 21%, respectively, for NHS II
in 1999). Vitamin A (o5%) and b-carotene (o3%) supplement
use were low in both cohorts.
We found no evidence that higher intakes of vitamin C, vitamin
E, retinol, or b-carotene, the major carotenoid with provitamin A
activity, are associated with a lower risk of melanoma (Table 2).
Specific tocopherols (a-tocopherol, b-tocopherol, d-tocopherol, g-
tocopherol) and other carotenoids, with or without provitamin A
activity (a-carotene, lycopene, b-cryptoxanthin, lutein, and zeax-
anthin), were also unrelated to risk (data not shown). Age-adjusted
relative risks were only modestly attenuated when adjusted for the
other melanoma risk factors.
Rather than the hypothesised inverse relation, we observed a
positive association between dietary vitamin C and melanoma.
Women with intakes X175mgday
 1 had an RR of 1.43 (95% CI
1.02–2.00) compared to those with intakes o90mgday
 1. The
dose – response association was also marginally significant
(P¼0.05). A significant linear relation remained when vitamin E,
retinol, and b-carotene were added to the model (P¼0.03).
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melanoma risk (Table 3). Current use of multivitamins (a major
source of retinol), and supplements of vitamins C and E were all
unassociated with risk, and there was also no indication of benefit
with longer duration of use. Vitamin A and b-carotene supplement
use were too low to provide sufficient power for analysis.
Total fruits and vegetables or those with a high carotenoid
content (X2000IUserving
 1) were also not associated with a
lower risk of melanoma (Table 4) (see Feskanich et al (2000) for a
description of the fruits and vegetables). However, consumption of
fruits and vegetables high in vitamin C (X30mg serving
 1) was
significantly associated with an increasing risk (P for linear
trend¼0.01). Orange juice was the major contributor to dietary
vitamin C (about 20% in both cohorts), and X1servingday
 1 was
associated with an elevated risk of melanoma when compared to
no orange juice consumption (RR¼1.61, 95% CI 0.92–2.84, P for
linear trend¼0.008). In the NHS cohort, women recalled their
frequency of orange juice consumption during high school, and
this too was associated with an increased risk of melanoma (RR¼
1.59, 95% CI 1.17–2.18 for X1servingday
 1 vs o1servingweek
 1).
When analysed in the same model, significant positive dose–
response relations were observed for both adult (P¼0.01) and
high school (P¼0.04) orange juice consumption. In an analysis of
consistent intake over time, women who reported that they
consumed X1servingday
 1 of orange juice in both high school
and as an adult had an RR of 2.32 (95% CI 1.36–4.00) compared to
those who reported o1 serving week
 1 in both time periods.
Since dietary vitamin C was not expected to be a risk factor for
melanoma, we speculated that the positive associations might be
because of greater sun exposure among women with higher
vitamin C intakes. The highest incidences of melanoma were found
among the NHS women who lived in Florida (43 out of
100000year
 1) and California (31 out of 100000year
 1), states
where excessive sun exposure is more likely. However, their
dietary intakes of vitamin C were not higher than the rest of the
cohort and excluding them from analyses did not change results
from those in Table 2 that were adjusted for state of residence.
Since nondietary determinants of melanoma contribute sig-
nificantly to risk, we examined associations between vitamins A, C,
E, and melanoma separately among women at higher and lower
risk based upon nondietary factors. A total risk score was
calculated using cohort-derived RRs associated with each of the
five nondietary factors listed in Table 1. The lowest score of 5 was
assigned to women with the lowest relative risk (RR¼1.0) for all
factors; the highest risk scores were 11.9 in NHS and 14.3 in NHS
II. Categories of low, middle, and high risk were defined to ensure
Table 1 Age-standardised characteristics
a within the low and high categories of vitamin C, vitamin E, retinol, and b-carotene intakes from foods plus
supplements among the women in the NHS (n=73432) and NHS II (n=88541) study populations
Daily total intake
Vitamin C (mg) Vitamin E (mg
b) Retinol (lg) b-Carotene (lg)
o100 X400 o9 X50 o400 X1800 o2400 X6000
NHS women
Median daily intake 86 694 8 187 285 2469 1907 7455
Age (years) 54 58 55 58 54 56 54 58
Postmenopausal (%) 57 73 62 76 59 73 57 77
Postmenopausal hormone user
c (%) 27 41 26 43 28 38 30 37
Nulliparous (%) 6 8 6 7 6 7 6 7
Body mass index (kgm
 2) 25.7 25.1 25.6 25.1 25.4 25.2 25.6 25.2
Height (cm) 164 164 164 164 164 164 0164 164
Nondietary risk factors
Painful burn or blisters during
childhood after 2h in sun (%) 15 15 14 15 15 15 15 15
6+ sunburns in lifetime (%) 55 58 53 59 56 57 57 55
3+ moles on left arm (%) 12 13 12 13 12 12 12 12
Red or blonde hair (%) 15 16 15 16 15 17 15 16
Parent or sibling with melanoma (%) 3 4 3 4 3 4 4 4
NHS II women
Median daily intake 85 690 8 187 296 2375 1763 7721
Age (years) 39 41 39 42 40 39 40 42
Premenopausal (%) 88 86 89 84 87 88 89 87
Oral contraceptive user
d (%) 10 10 10 10 10 9 10 9
Nulliparous (%) 20 33 21 31 23 25 21 27
Body mass index (kgm
 2) 26.0 24.9 25.4 24.7 25.6 25.0 25.9 25.2
Height (cm) 164 164 164 164 165 165 165 165
Nondietary risk factors
Painful burn or blisters during
childhood after 2h in sun (%) 25 25 24 25 24 25 25 25
3+ sunburns in teen years (%) 28 28 26 27 28 27 27 28
5+ moles on lower legs (%) 21 22 21 23 21 22 22 21
Red or blonde hair (%) 19 22 20 22 19 22 20 21
Parent or sibling with melanoma (%) 5 6 5 6 5 5 5 5
aValues are means or percentages of the population within categories of nutrient intakes and are standardised to the age distribution of the study populations over follow-up
(NHS 1984–1998; NHS II 1991–1999).
bmg of a-tocopherol equivalents.
cPercent postmenopausal hormone users is calculated among postmenopausal women only.
dPercent
oral contraceptive users is calculated among premenopausal women only.
Vitamins A,C,E and melanoma
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a
Cases
Person-years
(thousands)
Age-adjusted
b
RR (95% CI
d)
Multivariate
c
RR (95% CI
d)
Vitamin C (mg)
Total
e
o110 60 315 1.00 1.00
110–159 89 363 1.26 (0.73–2.19) 1.21 (0.71–2.06)
160–219 78 312 1.31 (0.93–1.84) 1.21 (0.86–1.71)
220–399 81 323 1.31 (0.93–1.85) 1.19 (0.84–2.68)
X400 106 335 1.50 (0.78–2.89) 1.33 (0.74–2.38)
P for linear trend 0.27 0.53
Dietary
f
o90 57 325 1.00 1.00
90–114 73 307 1.32 (0.93–1.87) 1.27 (0.90–1.80)
115–139 74 322 1.29 (0.91–1.82) 1.24 (0.87–1.76)
140–174 112 353 1.72 (1.24–2.37) 1.62 (1.17–2.25)
X175 98 341 1.51 (1.08–2.11) 1.43 (1.02–2.00)
P for linear trend 0.04 0.05
Vitamin E (mg
g)
Total
e
o9.0 72 343 1.00 1.00
9.0–10.9 85 317 1.25 (0.77–2.04) 1.19 (0.75–1.90)
11.0–16.9 77 318 1.15 (0.83–1.59) 1.05 (0.76–1.45)
17.0–49.9 89 357 1.18 (0.68–2.07) 1.09 (0.64–1.83)
X50.0 91 313 1.25 (0.70–2.23) 1.11 (0.66–1.85)
P for linear trend 0.30 0.54
Dietary
f
o8.0 75 324 1.00 1.00
8.0–8.9 86 369 0.99 (0.73–1.36) 0.96 (0.70–1.31)
9.0–9.9 103 385 1.14 (0.85–1.54) 1.07 (0.79–1.44)
10.0–10.9 81 264 1.30 (0.95–1.78) 1.21 (0.88–1.66)
X11.0 69 306 0.93 (0.58–1.50) 0.88 (0.59–1.32)
P for linear trend 0.80 0.98
Retinol (mg)
Total
e
o400 87 322 1.00 1.00
400–699 71 351 0.75 (0.54–1.02) 0.72 (0.53–0.99)
700–1099 78 317 0.90 (0.66–1.23) 0.85 (0.63–1.16)
1100–1799 95 335 1.03 (0.77–1.38) 0.97 (0.72–1.30)
X1800 83 324 0.92 (0.68–1.24) 0.85 (0.63–1.16)
P for linear trend 0.80 0.52
Dietary
f
o300 79 309 1.00 1.00
300–424 76 332 0.90 (0.65–1.24) 0.88 (0.62–1.26)
425–599 95 368 1.03 (0.76–1.39) 0.99 (0.73–1.35)
600–849 74 317 0.91 (0.66–1.26) 0.87 (0.63–1.20)
X850 90 323 1.08 (0.75–1.56) 1.07 (0.74–1.55)
P for linear trend 0.96 0.99
b-Carotene
h (mg)
Total
5
o2400 56 320 1.00 1.00
2400–3399 111 358 1.75 (1.25–2.40) 1.67 (1.20–2.30)
3400–4399 73 320 1.24 (0.79–1.93) 1.17 (0.79–1.73)
4400–5999 94 331 1.54 (1.10–2.16) 1.44 (1.02–2.02)
X6000 80 320 1.33 (0.92–1.93) 1.22 (0.86–1.74)
P for linear trend 0.59 0.96
aResults from NHS and NHS II were pooled to obtain risk estimates for the combined cohorts. All P-values were >0.05 in tests for heterogeneity.
bRelative risks were adjusted
for age and follow-up cycle. In addition, dietary vitamin C was adjusted for vitamin C supplement use; dietary vitamin E was adjusted for vitamin E supplement use; and dietary
retinol was adjusted for multivitamin use and vitamin A supplement use.
cRelative risks were adjusted for the covariates listed above plus the following: skin reaction after 2h of
sun exposure during childhood, number of sunburns over lifetime (NHS) or during teenage years (NHS II), number of moles on left arm (NHS) or on lower legs (NHS II), hair
colour, family history of melanoma, state of residence, menopausal status, oral contraceptive use, postmenopausal hormone use, parity, height, and body mass index.
d95%
confidence interval.
eTotal nutrient intakes are from foods plus supplements.
fDietary nutrient intakes are from foods only.
gMilligram of a-tocopherol equivalents.
hb-carotene
analyses for dietary intake were very similar to analyses of total intake because of low use of b-carotene supplements.
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shows results for dietary vitamin C and total retinol, the only
nutrients which exhibited possible interactions with the risk score.
For dietary vitamin C, a significant positive association was found
only among women in the high-risk category (P for linear
trend¼0.01), although the test for interaction was not significant
(P¼0.12). For total retinol, a significant inverse association was
observed in the low-nondietary-risk category. An RR of 0.39 (95%
CI 0.22–0.71) was associated with a total retinol intake of
X1800mgday
 1 when compared to o400mgday
 1 (P for linear
trend¼0.01) and there was a significant interaction between total
retinol and risk score (P¼0.001).
DISCUSSION
In this prospective study within two large cohorts of Caucasian
women 25–77 years of age, we found little evidence that vitamin C,
vitamin E, individual tocopherols, retinol, b-carotene, or other
carotenoids are associated with a lower risk of invasive melanoma.
The only inverse association that we observed was for total retinol
intake when limited to women who were otherwise at low risk of
melanoma based on nondietary factors. Although not an
antioxidant, retinol is essential for regulating cell differentiation,
and it is possible that it may only exert a notable effect without the
overwhelming influence of other major risk factors. There is little
prior research to support our finding. Breslow et al (1995)
reported an RR of 0.4 when comparing extreme tertiles of plasma
retinol levels, although there were only 30 melanoma cases in this
analysis and results were not significant. Other case–control
studies did not find an association between plasma (Stryker et al,
1990; Knekt et al, 1991) or dietary (Stryker et al, 1990; Kirkpatrick
et al, 1994) levels of retinol and risk of melanoma. It is possible
that our observed inverse association for total retinol intake
among the low-risk women is a chance finding, but even if real, we
would not recommend high retinol intakes for women at such low
risk of melanoma since higher intakes have been associated with
increased risk of hip fracture among postmenopausal women
(Feskanich et al, 2002).
An unexpected finding was the increased risk of melanoma with
higher intakes of vitamin C from food, and more frequent
consumption of fruits and vegetables high in vitamin C,
particularly orange juice. It is possible that this, too, is a chance
finding. However, given that this association was strongest among
the higher risk sun-sensitive women, it is also possible that a
photosensitising compound in these foods is responsible for the
increased risk; vitamin C is unlikely to be responsible because
supplement users were not at higher risk. Furocoumarins are
naturally produced in fruits and vegetables in response to physical
damage, fungal infection, and attack by pests, and they exhibit
phototoxic effects because of their capacity to absorb photons and
then release the energy to cause cellular damage (Gasparro et al,
1997). Plants of the umbelliferae family, such as parsnips, celery,
fennel, and parsley, have a high furocoumarin content, and
dermatologic reactions have been observed with ingestion of large
quantities and subsequent exposure to UV radiation (Ljunggren,
1990; Puig and Demaragas, 1994). Some types of limes (Nigg et al,
1993) and oranges (Joint Food Safety and Standards Group, Food
Standard Agency, UK, 1993) also contain appreciable quantities of
furocoumarins and have been noted to trigger dermatologic
Table 3 Relative risks (RRs) of melanoma by use of vitamin
supplements
a
Person-years Multivariate
b
Cases (thousands) RR (95% CI
c)
Multivitamins
Never 143 596 1.00
Past 83 302 0.96 (0.51–1.83)*
Current 185 700 1.02 (0.82–1.28)
Vitamin C Supplements
Never 231 973 1.00
Past 51 209 0.97 (0.71–1.32)
Current 129 416 1.07 (0.64–1.77)*
Vitamin E Supplements
Never 292 1189 1.00
Past 40 141 0.98 (0.70–1.38)
Current 79 268 1.02 (0.79–1.33)
nPo0.05 in test for heterogeneity of results from NHS and NHS II.
aResults from
NHS and NHS II were pooled to obtain risk estimates for the combined cohorts.
bRelative risks were adjusted for the covariates listed in Table 2 footnote c. In
addition, vitamin C supplement use was adjusted for vitamin C from food and vitamin
E supplement use was adjusted for vitamin E from food.
c95% confidence interval.
Table 4 Relative risks (RRs) of melanoma by daily servings of fruits and
vegetables and by frequency of consumption of orange juice
a
Person-years Multivariate
b
Cases (thousands) RR (95% CI
c)
Total fruits
o1.0 62 349 1.00
1.0–1.4 58 274 1.16 (0.80–1.66)
1.5–2.4 151 524 1.42 (0.99–2.04)
2.5–3.4 83 303 1.37 (0.95–1.98)
X3.5 60 198 1.37 (0.86–2.20)
P for linear trend 0.22
Total vegetables
o2.0 86 448 1.00
2.0–2.9 126 479 1.22 (0.92–1.62)
3.0–3.9 106 356 1.32 (0.97–1.78)
4.0–4.9 53 196 1.11 (0.76–1.62)
X5.0 43 169 1.01 (0.68–1.50)
P for linear trend 0.81
Fruits and vegetables high in carotenoids
o0.25 50 263 1.00
0.25–0.49 116 447 1.30 (0.51–3.33)*
0.50–0.74 85 347 1.18 (0.49–2.85)*
0.75–0.99 68 236 1.40 (0.73–2.68)
X1.00 95 355 1.24 (0.67–2.29)
P for linear trend 0.78
Fruits and vegetables high in vitamin C
o0.5 57 317 1.00
0.5–0.9 77 376 1.10 (0.77–1.55)
1.0–1.4 96 378 1.33 (0.94–1.87)
1.5–1.9 92 280 1.54 (1.06–2.22)
X2.0 92 297 1.43 (0.99–2.07)
P for linear trend 0.01
Orange juice
d
Never 39 228 1.00
1–3month
 1 70 364 1.09 (0.73–1.62)
1week
 1 44 197 1.31 (0.83–2.05)
2–6week
 1 203 799 1.44 (1.00–2.08)
X1day
 1 147 499 1.61 (0.92–2.84)
P for linear trend 0.008
nPo0.05 in test for heterogeneity of results from the NHS and NHS II.
aResults from
NHS (1984–1998) and NHS II (1991–1999) were pooled to obtain risk estimates
for the combined cohorts.
bRelative risks were adjusted for the covariates listed in
Table 2 footnote c plus total energy intake, multivitamin use, and use of vitamin C,
vitamin E, and b-carotene supplements.
c95% confidence interval.
dFollow-up for
NHS is 1980 – 1998.
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Wagner et al, 2002). Psoralen is a furocoumarin that has long been
used with UV A radiation to treat psoriasis and other skin
conditions (Parrish et al, 1974) and more recently has been
associated with higher risk of squamous cell cancer (Lever and
Farr, 1994; Stern et al, 1998) and melanoma (Stern et al, 1997).
Whether the amounts of furocoumarins in orange juice, when
ingested over many years, are sufficient to affect risk of melanoma
in susceptible individuals is unclear.
The major strength of this study is the prospective design;
previous research has been limited to retrospective studies. Other
strengths are the wide age distribution of women, the repeated
measures of diet and supplement use, and the ability to control for
several major risk factors for melanoma. Although we lacked
lifetime information on time spent in the sun, the risk factor data
that we did collect were unrelated to diet and therefore did not
confound results.
In conclusion, higher intakes of vitamins C, E, and A were
generally not associated with lower risks of melanoma in
Caucasian women, although retinol may be protective among
women who are otherwise at low risk of disease. Certain foods,
such as orange juice, may be associated with an increased risk of
melanoma, but further research is needed to confirm this finding
and to identify the responsible constituents in these foods.
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